[PDF][PDF] Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer
V Goodell, LG Salazar, N Urban, CW Drescher… - Journal of Clinical …, 2006 - Citeseer
V Goodell, LG Salazar, N Urban, CW Drescher, H Gray, RE Swensen, MW McIntosh…
Journal of Clinical Oncology, 2006•CiteseerPurpose Presence of intratumoral T-cell infiltration has been linked to improved survival in
ovarian cancer patients. We questioned whether antibody immunity specific for ovarian
cancer tumor antigens would predict disease outcome. We evaluated humoral immune
responses against ovarian cancer antigens p53, HER-2/neu, and topoisomerase IIα.
ovarian cancer patients. We questioned whether antibody immunity specific for ovarian
cancer tumor antigens would predict disease outcome. We evaluated humoral immune
responses against ovarian cancer antigens p53, HER-2/neu, and topoisomerase IIα.
Purpose
Presence of intratumoral T-cell infiltration has been linked to improved survival in ovarian cancer patients. We questioned whether antibody immunity specific for ovarian cancer tumor antigens would predict disease outcome. We evaluated humoral immune responses against ovarian cancer antigens p53, HER-2/neu, and topoisomerase IIα.
Citeseer